What's new
Research made readable — screening, treatment advances and the studies that matter, explained in plain language and filed under the topics you came to understand.
No reports match your search
Try a different term, or clear your search.
Shortly after the U.S. Food and Drug Administration (FDA) rejected approval of the drug Avastin to treat breast cancer, two newly published studies showed some benefits of Avastin in treating ovarian cancer. Avastin is FDA-approved to treat some colorectal, lung, brain, and kidney cancers.
Cancer Articles Date Early Research Shows that Removing Ovaries May Not be Necessary to Reduce Ovarian Cancer Risk Nov 2011 Study: Removing Breasts or Ovaries Appears to Effectively Prevent Cancer in High-Risk Women Sep 2010 2000-2007 Consensus Statement Released on Ovarian Cancer Symptoms Jul 29, 2007 Stu
Cancer A new study finds that long-term outcomes after breast-conserving surgery are the same, regardless of whether chemotherapy is given before or after surgery. Instead, the study suggests that biological factors have a greater impact than the time of chemotherapy.
Cancer Researchers have known for years that women carrying BRCA (breast cancer gene) mutations have a higher risk of breast cancer. Now, a recent study shows that those women are being diagnosed with breast cancer earlier than women without the genetic mutations.
Cancer Friday, October 21, 2011, has been designated National Mammography Day in the United States. Imaginis encourages women to use this day as a reminder to make an appointment to get a mammogram.
Cancer Some women at high risk of ovarian cancer have opted to have their ovaries removed to reduce their cancer risk. Now, a recent study suggests that removing the ovaries may not be necessary to reduce the risk of ovarian cancer in high risk women.
Cancer An FDA advisory panel vetoed to remove the approval of Avastin to for treating advanced breast cancer in combination with chemotherapy, citing that the benefits do not appear to exceed the risks of the drug.
Cancer A recent study finds that Aromasin may reduce the risk of breast cancer in women at high risk of developing the disease. Aromasin has been used by physician for a decade to treat advanced breast cancer in some women. In the study, Aromasin decreased breast cancer risk by nearly two thirds.
Breast Health A large study finds that women with early-stage breast cancer who take tamoxifen for five years have less risk that their cancer will return compared to women who take the drug for two years.
Heart & Brain Health The American Heart Association reported that the cost to treat heart disease in the United States will triple by the year 2030. Between 2010 and 2030, the cost of medical care for heart disease will rise from $273 billion to $818 billion. That’s an increase of $545 billion.
Plain-language references and tools beyond the news.
Health glossaryPlain-language definitions for 150+ medical terms — from biopsy and BRCA to staging and ultrasound.
Browse A–ZVoices from physicians, survivors and caregivers.
One thoughtful email a month — never spam.
This is health information, not medical advice.